Literature DB >> 8894117

Biopharmaceutical evaluation of the liposomes prepared by rehydration of freeze-dried empty liposomes (FDELs) with an aqueous solution of a drug.

K Yachi1, H Harashima, H Kikuchi, R Sudo, H Yamauchi, K Ebihara, H Matsuo, K Funato, H Kiwada.   

Abstract

We have evaluated a method for preparation of a dispersion of liposomes encapsulating a drug, namely rehydration of freeze-dried empty (not containing drug) liposomes with an aqueous drug solution (FDEL method). In the present study, we characterized and compared this method with the conventional method using a lipid composition of DPPC-DPPG-cholesterol in a molar ratio of 27:3:20. Two hydrophilic compounds, [3H]-inulin and [3H]-mannitol, were used as model drugs. Liposomal preparations by the FDEL method had an encapsulation efficiency of 2.9 and 6.7% for [3H]-inulin and [3H]-mannitol, respectively, when rehydrated and incubated at 70 degrees C. Since non-specific adsorption of these markers to liposomal membrane is negligible, this method produces liposomes which encapsulate a drug in the intravesicular space. One-tenth of the marker encapsulated in the liposomes prepared by the FDEL method (F-liposomes) was released very rapidly on incubation with rat plasma, followed by the slow release of the remaining fraction thereafter. No such rapid-release phase was observed for the liposomes prepared by the conventional method (C-liposomes). This suggests the existence of two types of encapsulation, loose encapsulation and tight encapsulation, in F-liposomes at least. Pharmacokinetic parameters of marker encapsulated tightly in F-liposomes were comparable to those in C-liposomes. It is likely that amphipathic drugs such as doxorubicin are incorporated into liposomes more easily than inulin and mannitol when formulated by the FDEL method. These results therefore suggest that the FDEL method is useful in the preparation of a liposomal formulation of a drug.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8894117     DOI: 10.1002/(SICI)1099-081X(199610)17:7<589::AID-BDD976>3.0.CO;2-D

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  4 in total

1.  Hepatic immunopotentiation by galactose-entrapped liposomal IL-2 compound in the treatment of liver metastases.

Authors:  K Okuno; K Nakamura; A Tanaka; K Yachi; M Yasutomi
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

2.  Nanoformulation of Geranylgeranyltransferase-I Inhibitors for Cancer Therapy: Liposomal Encapsulation and pH-Dependent Delivery to Cancer Cells.

Authors:  Jie Lu; Kohei Yoshimura; Koichi Goto; Craig Lee; Ken Hamura; Ohyun Kwon; Fuyuhiko Tamanoi
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

Review 3.  Gene Delivery Technologies with Applications in Microalgal Genetic Engineering.

Authors:  Sergio Gutiérrez; Kyle J Lauersen
Journal:  Biology (Basel)       Date:  2021-03-26

4.  Nanoparticles Containing Curcumin Useful for Suppressing Macrophages In Vivo in Mice.

Authors:  Chie Amano; Hideki Minematsu; Kazuyo Fujita; Shinki Iwashita; Masaki Adachi; Koichi Igarashi; Shuji Hinuma
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.